• SENSEX
    NIFTY 50
Earnings

This pharma stock rallied 13% post Q1 earnings; here's what brokerages advise

Updated : July 31, 2020 01:25 PM IST

The stock rose as much as 10 percent to Rs 2,680.50 per share on BSE.
Brokerages Citi and CLSA maintain buy calls on the stock. CLSA also raised the stock's target price to Rs 3,100 from Rs 2,920 earlier.
This pharma stock rallied 13% post Q1 earnings; here's what brokerages advise

You May Also Like

Live TV
Advertisement